• Pomdoctor launched preparations to enter the U.S. market, starting a phased expansion plan focused on pilot validation.
• Initial U.S. pilots target remote patient monitoring and chronic disease management, with broader rollout contingent on results.
• Recruitment began for U.S.-based leadership and operations roles, alongside development of a local compliance and regulatory framework.
• Product localization is underway, with exploratory talks opened with potential U.S. healthcare partners.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN34990) on August 27, 2026, and is solely responsible for the information contained therein.